Post-Exposure Management for Needle Prick Injury with Syphilis Risk

Introduction to Syphilis Transmission Risk

The risk of syphilis transmission through needle prick injury is substantially lower than for other bloodborne pathogens, with Hepatitis B transmission risk exceeding 30% without prophylaxis and HIV transmission risk approximately 0.36% after percutaneous injury with infected blood, according to the Centers for Disease Control and Prevention (CDC) 1, 3, 4, 5

The primary reason for low syphilis transmission risk is that Treponema pallidum has poor survival outside the human body and requires direct contact with infectious lesions for efficient transmission, as noted by the CDC 6
Blood contains spirochetes primarily during early syphilis stages, but the concentration is typically insufficient for transmission via needlestick, according to the CDC 6

Follow standard needlestick injury protocols, including washing the wound immediately with soap and water, as recommended by the CDC 1, 2, 7
Do not squeeze the wound or apply caustic agents like bleach, as advised by the CDC 1, 2
Document the exposure details including date, time, type of needle, depth of injury, and whether blood was visible, as suggested by the CDC 4, 7

Determine the syphilis status of the source patient if possible, using treponemal and non-treponemal tests, as recommended by the CDC 6, 7
Document the stage of syphilis if positive, according to the CDC 6

Consider prophylactic treatment with benzathine penicillin G 2.4 million units intramuscularly as a single dose for high-risk exposures, as suggested by the CDC 6
Alternative for penicillin-allergic patients: Doxycycline 100 mg orally twice daily for 14 days, although this is based on early syphilis treatment and not specifically studied for needlestick injuries 5

Establish baseline and conduct serial testing at 0, 4-6 weeks, and 3 months, as recommended by the CDC 6, 7
The documented case of syphilis seroconversion after needlestick showed positive serology at 90 days, emphasizing the importance of 3-month follow-up, although the specific details of this case are not provided 6

HIV PEP should be initiated immediately if indicated, using bictegravir/emtricitabine/tenofovir alafenamide or dolutegravir-based regimens for 28 days, as recommended by the CDC 8, 5, 9
Hepatitis B prophylaxis: Administer HBIG and initiate or complete hepatitis B vaccine series if the exposed person is unvaccinated and source is HBsAg-positive, according to the CDC 3, 7
Hepatitis C monitoring: No prophylaxis available; perform baseline anti-HCV and ALT, then repeat at 4-6 months, as suggested by the CDC 4, 7